New Computed Tomography System Offers Potential Benefits in Cardiac Imaging

Fujifilm Healthcare Americas Corporation has launched the Scenaria View Focus Edition computed tomography (CT) system, a device that may enhance cardiac imaging and reportedly reduces radiation dosing by up to 83 percent.

The Scenaria View Focus Edition, which received 510(k) clearance from the Food and Drug Administration (FDA) in April 2022, may be utilized for a variety of routine and advanced applications, including dual energy exams, interventional radiology procedures and coronary computed tomography angiography (CCTA), according to the company. The new CT system will be showcased at the upcoming Radiological Society of North America (RSNA) annual meeting November 27 to December 1 in Chicago.

Fujifilm said a unique feature of the Scenaria View Focus Edition CT system is the Cardio StillShot, a cardiac motion correction tool, which captures two data sets in each scan that are subsequently compared to help detect and correct heart motion. The Cardio StillShot allows temporal resolution of 28 milliseconds with final images in comparison to 175 milliseconds with conventional image reconstruction, according to Fujifilm.

In comparison to conventional filtered back projection image reconstruction, Fujifilm said the Scenaria View Focus Edition’s use of iterative reconstruction reduces radiation dosing by up to 83 percent and reduces image noise by up to 90 percent.

“Providers need a powerful CT system that gives them the diagnostic confidence to make the right treatment decisions for their patients,” noted Mark Silverman, the director of marketing for CT at Fujifilm Healthcare Americas Corporation. “Fujifilm’s Scenaria View Focus Edition makes this possible through the convergence of high temporal resolution, enhanced workflow that reduces examination time, and advanced dose reduction capabilities.”